William Richards

Mr. William Richards

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Journal of Tissue Engineering
Verified
Journal Article
Open access
JMJoydeb Majumder
Joydeb Majumder
ETElizabeth E Torr
Elizabeth E Torr
EAElizabeth A Aisenbrey
Elizabeth A Aisenbrey
CLConnie S Lebakken
Connie S Lebakken
PFPeter F Favreau
Peter F Favreau
WMWilliam L Murphy
William L Murphy
The tailorable properties of synthetic polyethylene glycol (PEG) hydrogels make them an attractive substrate for human organoid assembly. Here, we formed human neural organoids from iPSC-derived progenitor cells in two distinct formats: (i) cells seeded on a Matrigel surface; and (ii) cells seeded on a synthetic PEG hydrogel surface. Tissue assembly on synthetic PEG hydrogels resulted in three dimensional (3D) planar neural organoids with greater neuronal diversity, greater expression of neurovascular and neuroinflammatory genes, and reduced variability when compared with tissues assembled upon Matrigel. Further, our 3D human tissue assembly approach occurred in an open cell culture format and created a tissue that was sufficiently translucent to allow for continuous imaging. Planar neural organoids formed on PEG hydrogels also showed higher expression of neural, vascular, and neuroinflammatory genes when compared to traditional brain organoids grown in Matrigel suspensions. Further, planar neural organoids contained functional microglia that responded to pro-inflammatory stimuli, and were responsive to anti-inflammatory drugs. These results demonstrate that the PEG hydrogel neural organoids can be used as a physiologically relevant in vitro model of neuro-inflammation.

4 August 2025 in Current Research in Toxicology
Verified
Journal Article
Open access
NYNina Y Yuan
Nina Y Yuan
WRWilliam Richards
William Richards
KPKailyn T. Parham
Kailyn T. Parham
SCSophia G. Clark
Sophia G. Clark
KGKaylie Greuel
Kaylie Greuel
CLConnie Stechmann Lebakken
Connie Stechmann Lebakken
• Complex neuroimmune cerebral organoid model for use in mechanistic studies. • Neurotoxins evaluated via RNA-seq, cytokine and cell injury biomarkers. • Pathway and correlation analysis performed on RNA-seq results. • Findings suggest microglia may play a role in the neurotoxicity of lead (Pb) exposure.

1 January 2019 in Stem Cell Research
Verified
Journal Article
Open access
YYYingnan Yin
Yingnan Yin
APAndrew J. Petersen
Andrew J. Petersen
CSCheryl Soref
Cheryl Soref
WRWilliam Richards
William Richards
TLTenneille Ludwig
Tenneille Ludwig
Anita BhattacharyyaAnita Bhattacharyya
Anita Bhattacharyya
Seven human induced pluripotent stem cell (iPSC) lines were generated from fibroblasts from three neonatal individuals using non-integrative reprogramming. Most control iPSCs are derived from adults, so these iPSCs meet the need for control iPSCs from young individuals. Donors were from different ethnicities and these lines provide unique genetic profiles. All iPSCs have normal karyotypes, express stem cell markers, and exhibit pluripotency, as assessed by capacity to differentiate into three germ layers. These lines are valuable to study human development, as age-matched controls for disorder-specific iPSCs, and as platforms for gene editing to control for age and ethnicity.

1 November 2025 in Stroke
Verified
Journal Article
Closed access
CSCarina Seah
Carina Seah
BSBraxton R. Schuldt
Braxton R. Schuldt
JVJames M. Vicari
James M. Vicari
CLConnie Stechmann Lebakken
Connie Stechmann Lebakken
WRWilliam Richards
William Richards
CKChristopher Kellner
Christopher Kellner
BACKGROUND: Intracerebral hemorrhage leads to significant morbidity and mortality due to primary mechanical and secondary neurotoxic injury to brain parenchyma. Timing of surgical evacuation to ensure optimal outcomes is controversial, with recent evidence suggesting early intervention improves functional outcome. Here, we characterize the impact of blood-induced secondary injury on diverse brain cell types in a scalable organoid model of intracerebral hemorrhage. METHODS: Human neural organoids consisting of excitatory neurons, inhibitory neurons, neural progenitor cells, astrocytes, endothelial cells, and microglia were generated from induced pluripotent stem cell–derived cells and treated with 5% blood for either 6 or 24 hours. Organoids were dissociated and analyzed by single-cell RNA sequencing. RESULTS: Single-cell sequencing of 96 725 cells across 18 organoids resolved intermediate progenitors, neural progenitor cells, microglia, inhibitory neurons, endothelial cells, excitatory neurons, and astrocytes. Twenty-four-hour exposure to blood induced cellular reactivity, whereas 6-hour exposure did not. Intermediate progenitors, endothelial cells, and astrocytes were the most reactive to blood and exhibited gene expression patterns corresponding to astrocyte reactivity, angiogenesis, and progenitor cell ischemic excitotoxicity. Drug repurposing analysis identified neurotransmitter-modulating, vasculature-remodeling, and protein synthesis pathways as potential therapeutic targets, mitigating blood-induced neurotoxicity. CONCLUSIONS: Blood exposure induces transcriptomic changes in a temporal and cell type–specific manner, particularly mediated by astrocyte reactivity, angiogenesis, and impairment of neurogenesis. Early and complete removal of blood after 6 hours of blood exposure mitigates secondary neurotoxicity seen in 24-hour exposure to blood. Transcriptomic signatures of blood-mediated neurotoxicity may potentially be reversed by antiadrenergic, dopamine agonist, and vasodilatory mechanisms.

14 July 2026 in Cells
Verified
Journal Article
Open access
PDF file
NYNina Y Yuan
Nina Y Yuan
WRWilliam Richards
William Richards
KPKailyn T Parham
Kailyn T Parham
SCSophia G. Clark
Sophia G. Clark
CLConnie Stechmann Lebakken
Connie Stechmann Lebakken
Alzheimer’s Disease (AD) is a multifaceted progressive neurodegenerative disease characterized by memory deficits and cognitive impairment. The disease is clinically diagnosed by the presence of β-amyloid (Aβ), hyperphosphorylated tau, and neurodegeneration. Animal models serve as an indispensable tool to understanding AD pathogenesis and evaluating potential therapeutic approaches. However, despite the development of more than 200 rodent models, species-specific differences limit the translational relevance. Brain organoids generated from induced pluripotent stem cells (iPSCs) have the potential to bridge the gap between transgenic mouse models and clinical trials in human patients. Herein, we describe a robust stimulus-based neuroimmune organoid model that demonstrates neuroinflammation, neurodegeneration, and lipid dysregulation with AD-relevant pathological markers. Using planar organoids containing neurons, astrocytes, microglia, and vascular cells, we performed in-depth characterization of the induced AD-like phenotype using supernatant proteomic analysis, immunofluorescence staining, NfL and GFAP release, scRNAseq, bulk RNAseq, and pathway analysis both acutely (24 h) and chronically (7 days). Furthermore, we show that the induced neuroinflammation, lipid dysregulation, and neurodegeneration can be ameliorated using small molecules. This defined inducible model system presents an opportunity for drug discovery and development using a complex multicellular brain microenvironment derived from human iPSCs.

2 August 2026 in Organoids
Verified
Journal Article
Open access
PDF file
NYNina Y Yuan
Nina Y Yuan
WRWilliam Richards
William Richards
KPKailyn T Parham
Kailyn T Parham
KGKaylie Greuel
Kaylie Greuel
JZJoshua A. Zimmermann
Joshua A. Zimmermann
CLConnie Stechmann Lebakken
Connie Stechmann Lebakken
Glioblastoma (GBM) is a highly aggressive malignant brain tumor accounting for 15% of all brain tumors and 50% of all gliomas. The exact cause of GBM is not fully understood but risk factors include age, genetic mutations, exposure to ionizing radiation, and certain genetic disorders. Symptoms of GBM include headaches, seizures, cognitive impairment, and weaknesses on one side of the body. Myeloid cells account for 30–50% of the tumor mass and are instrumental in shaping the complex tumor microenvironment (TME). Inflammation in the TME is an important driver of tumor growth and invasion; however, as the environment evolves, the immunosuppressive TME poses a significant hurdle as it hinders the immune-mediated killing of tumor cells. Our work utilizes neuroimmune organoids containing neurons, astrocytes, microglia, and vascular-like cells, to which we add patient-derived GBM cells and/or iPSC-derived macrophages to model the GBM TME. Model characterization was performed using single-cell RNA sequencing and supernatant proteomics to determine cell-specific changes during coculturing. Our findings are consistent with this 7-day coculture model recapitulating key aspects of GBM early tumor establishment and immune activation, with transcriptomic and secretome signatures suggestive of an emerging immune evasion phenotype.